Synapse and FDA collaborate to swiftly generate real-world data (RWD) in COVID-19 patients with cancer
11 August 2022
The collaboration is already yielding useful results and aims to tackle the following:
- Investigating methods to derive RWD from multiple sources including electronic health records, registries and molecular data;
- Enhancing understanding of how patients respond to therapies outside of clinical trials to improve care and outcomes;
- Understanding the impact of COVID-19 on cancer care.